Fragmented care models for sleep medicine in Canada disadvantage individuals with socioeconomic barriers. This can lead to delays in diagnoses, treatment, and increased health care utilization.
Background:
Fragmented care models for sleep medicine in Canada disadvantages individuals with socioeconomic barriers. This can lead to delays in diagnoses, treatment, and increased health care utilization. This study aimed to explore whether subjects who receive polysomnography (PSG) during hospitalization represent a marginalised population.
Methods:
We identified subjects who underwent PSG during hospitalization (inpatient PSG) at an academic hospital in Canada, from January 1, 2019, to December 31, 2021. Time, age- and sex-matched control groups were derived in a 2:1 allocation ratio inclusive of: hospitalized individuals who did not undergo PSG (inpatient control) and individuals referred to an ambulatory sleep medicine clinic (clinic control). Comorbidities, socioeconomic deprivation and marginalization indices, rurality, and health care utilization within the preceding year to enrollment, were compared between groups.
Results:
We matched 275 inpatient PSG with 550 inpatient control and 550 clinic control subjects. Compared to both control groups, the inpatient PSG group had greater burden of comorbidities and more frequent specialist physician appointments. They had greater marginalization index, social assistance use, and lower income levels compared to clinic control subjects. More frequent emergency department visits, acute care admissions, and days in hospital were observed in the inpatient PSG group compared to clinic control subjects. Inpatient PSG subjects had more severe sleep disordered breathing (SDB) compared to clinic control subjects.
Conclusions:
Subjects evaluated with in-patient PSG had a greater multimorbidity, social disadvantages, and health care usage. Future prospective trials are needed to determine whether routine use of in-patient PSGs can reduce complications associated with untreated SDB.
LyonsMM, BhattNY, PackAI, et al.Global burden of sleep-disordered breathing and its implications. Respirology2020; 25: 690–702; doi: 10.1111/resp.13838
2.
HeinzerR, VatS, Marques-VidalP, et al.Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med2015; 3: 310–318; doi: 10.1016/S2213-2600(15)00043-0
3.
BenjafieldAV, AyasNT, EastwoodPR, et al.Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med2019; 7: 687–698; doi: 10.1016/S2213-2600(19)30198-5
4.
ShaharE, WhitneyCW, RedlineS, et al.Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med2001; 163: 19–25; doi: 10.1164/ajrccm.163.1.2001008
5.
NamtvedtSK, RandbyA, EinvikG, et al.Cardiac arrhythmias in obstructive sleep apnea (from the Akershus Sleep Apnea Project). Am J Cardiol2011; 108: 1141–1146; doi: 10.1016/j.amjcard.2011.06.016
6.
MehraR, BenjaminEJ, ShaharE, et al.; Sleep Heart Health Study. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med2006; 173: 910–916; doi: 10.1164/rccm.200509-1442OC
7.
MarinJM, SorianoJB, CarrizoSJ, et al.Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med2010; 182: 325–331; doi: 10.1164/rccm.200912-1869OC
8.
KonecnyT, KuniyoshiFHS, OrbanM, et al.Under-diagnosis of sleep apnea in patients after acute myocardial infarction. J Am Coll Cardiol2010; 56: 742–743; doi: 10.1016/j.jacc.2010.04.032
9.
JavaheriS, CarefEB, ChenE, et al.Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure. Am J Respir Crit Care Med2011; 183: 539–546; doi: 10.1164/rccm.201003-0406OC
10.
YaggiHK, ConcatoJ, KernanWN, et al.Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med2005; 353: 2034–2041; doi: 10.1056/NEJMoa043104
11.
KonikkaraJ, TavellaR, WillesL, et al.Early recognition of obstructive sleep apnea in patients hospitalized with COPD exacerbation is associated with reduced readmission. Hosp Pract (1995)2016; 44: 41–47; doi: 10.1080/21548331.2016.1134268
12.
NaranjoM, WillesL, PrillamanBA, et al.Undiagnosed OSA may significantly affect outcomes in adults admitted for COPD in an Inner-City Hospital. Chest2020; 158: 1198–1207; doi: 10.1016/j.chest.2020.03.036
13.
ScalzittiNJ, O’ConnorPD, NielsenSW, et al.Obstructive sleep apnea is an independent risk factor for hospital readmission. J Clin Sleep Med2018; 14: 753–758; doi: 10.5664/jcsm.7098
14.
SharmaS, MatherP, GuptaA, et al.Effect of early intervention with positive airway pressure therapy for sleep disordered breathing on six-month readmission rates in hospitalized patients with heart failure. Am J Cardiol2016; 117: 940–945; doi: 10.1016/j.amjcard.2015.12.032
15.
PendharkarSR, PovitzM, BansbackN, et al.; Canadian Sleep and Circadian Network. Testing and treatment for obstructive sleep apnea in Canada: funding models must change. CMAJ2017; 189: E1524–E1528; doi: 10.1503/cmaj.170393
16.
SharmaS and StansburyR. Sleep-disordered breathing in hospitalized patients: a game changer? Chest2022; 161: 1083–1091; doi: 10.1016/j.chest.2021.10.016
17.
SharmaS. Hospital sleep medicine: the elephant in the room? J Clin Sleep Med2014; 10: 1067–1068; doi: 10.5664/jcsm.4100
18.
SharmaS, MatherPJ, EfirdJT, et al.Obstructive sleep apnea in obese hospitalized patients: a single center experience. J Clin Sleep Med2015; 11: 717–723; doi: 10.5664/jcsm.4842
19.
GuglielmiO, LanteriP and GarbarinoS. Association between socioeconomic status, belonging to an ethnic minority and obstructive sleep apnea: a systematic review of the literature. Sleep Med2019; 57: 100–106; doi: 10.1016/j.sleep.2019.01.042
20.
Etindele SossoFA and MatosE. Socioeconomic disparities in obstructive sleep apnea: a systematic review of empirical research. Sleep Breath2021; 25: 1729–1739; doi: 10.1007/s11325-020-02274-z
21.
GoringK and CollopN. Sleep disordered breathing in hospitalized patients. J Clin Sleep Med2008; 4: 105–110; doi: 10.5664/jcsm.27125
22.
ShahidA, KhairandishA, GladanacB, et al.Peeking into the minds of troubled adolescents: the utility of polysomnography sleep studies in an inpatient psychiatric unit. J Affect Disord2012; 139: 66–74; doi: 10.1016/j.jad.2012.01.034
23.
TuK, CampbellNR, ChenZ-L, et al.Accuracy of administrative databases in identifying patients with hypertension. Open Med2007; 1: e18–e26; doi: 20101286
24.
HuxJE, IvisF, FlintoftV, et al.Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care2002; 25: 512–516; doi: 10.2337/diacare.25.3.512
GershonAS, WangC, GuanJ, et al.Identifying patients with physician-diagnosed asthma in health administrative databases. Can Respir J2009; 16: 183–188; doi: 10.1155/2009/963098
27.
GershonAS, WangC, GuanJ, et al.Identifying individuals with physician diagnosed COPD in health administrative databases. COPD2009; 6: 388–394; doi: 10.1080/15412550903140865
28.
FleetJL, DixonSN, ShariffSZ, et al.Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes. BMC Nephrol2013; 14: 81; doi: 10.1186/1471-2369-14-81
29.
QuanH, LiB, SaundersLD, et al.; IMECCHI Investigators. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res2008; 43: 1424–1441; doi: 10.1111/j.1475-6773.2007.00822.x
30.
KokotailoRA and HillMD. Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke2005; 36: 1776–1781; doi: 10.1161/01.STR.0000174293.17959.a1
31.
GoldbergD, LewisJ, HalpernS, et al.Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database. Pharmacoepidemiol Drug Saf2012; 21: 765–769; doi: 10.1002/pds.3290
32.
KendallCE, WongJ, TaljaardM, et al.A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario. BMC Public Health2014; 14: 161; doi: 10.1186/1471-2458-14-161
33.
BenchimolEI, GuttmannA, MackDR, et al.Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada. J Clin Epidemiol2014; 67: 887–896; doi: 10.1016/j.jclinepi.2014.02.019
34.
QuanH, SundararajanV, HalfonP, et al.Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care2005; 43: 1130–1139; doi: 10.1097/01.mlr.0000182534.19832.83
35.
JaakkimainenL, BayoumiI, GlazierRH, et al.Development and validation of an algorithm using health administrative data to define patient attachment to primary care providers. J Health Organ Manag2021;733–743; doi: 10.1108/JHOM-05-2020-0171
36.
PampalonR, HamelD, GamacheP, et al.An area-based material and social deprivation index for Public Health in Québec and Canada. Can J Public Health Rev Can Santee Publique2012; 103: S17–S22.
37.
PovitzM, Bray JenkynK, KendzerskaT, et al.Clinical pathways and wait times for OSA care in Ontario, Canada: a population cohort study. Can J Respir Crit Care Sleep Med2019; 3: 91–99; doi: 10.1080/24745332.2018.1512841
38.
KendzerskaT, GershonAS, TomlinsonG, et al.The effect of patient neighborhood income level on the purchase of continuous positive airway pressure treatment among patients with sleep apnea. Ann Am Thorac Soc2016; 13: 93–100; doi: 10.1513/AnnalsATS.201505-294OC
39.
ThorntonCS, PovitzM, TsaiWH, et al.Impact of wait times for treatment on clinical outcomes in patients with obstructive sleep apnoea: protocol for a randomised controlled trial. ERJ Open Res2022; 8: e00068-2022; doi: 10.1183/23120541.00068-2022
40.
CorriganJ, TsaiWH, Ip-ButingA, et al.Treatment outcomes among rural and urban patients with obstructive sleep apnea: a prospective cohort study. J Clin Sleep Med2022; 18: 1013–1020; doi: 10.5664/jcsm.9776
41.
JohnsonKG, RastegarV, ScuderiN, et al.PAP therapy and readmission rates after in-hospital laboratory titration polysomnography in patients with hypoventilation. J Clin Sleep Med2022; 18: 1739–1748; doi: 10.5664/jcsm.9962
42.
KendzerskaT, PendharkarSR, TalaricoR, et al.Understanding inpatient sleep studies for sleep-disordered breathing: A retrospective population-based study of health administrative databases. Chest2024; 166: A6150–A6151; doi: 10.1016/j.chest.2024.06.3639
43.
Alberta Health Service. Data & Analytics AHS. Annual Quick Facts 2023–2024. Alberta Health Service, 2024.
44.
KhayatR, AbrahamW, PattB, et al.Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. J Card Fail2012; 18: 534–540; doi: 10.1016/j.cardfail.2012.05.003
45.
KhayatRN, PorterK, GermanyRE, et al.Clinical and financial impact of sleep disordered breathing on heart failure admissions. Sleep Breath2023; 27: 1917–1924; doi: 10.1007/s11325-023-02813-4
46.
KhayatRN, JavaheriS, PorterK, et al.In-hospital management of sleep apnea during heart failure hospitalization: a randomized controlled trial. J Card Fail2020; 26: 705–712; doi: 10.1016/j.cardfail.2020.06.007
47.
SharmaS, MukhtarU, KellyC, et al.Recognition and treatment of sleep-disordered breathing in obese hospitalized patients may improve survival. The HoSMed Database. Am J Med2017; 130: 1184–1191; doi: 10.1016/j.amjmed.2017.03.055
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
